Health
Model simulations show no need for DEX dose adjustments in COVID-19 patients with liver disease – News-Medical.net
A recent study sed PBPK modeling to demonstrate the use of DEX PKs for the treatment of COVID-19 in patients with liver impairment….
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Wuhan, China, in December 2019. Studies have shown that between 3% to 8% of coronavirus disease 2019 (COVID-19) patients have pre-existing chronic liver disease (LD)….
Continue Reading
-
General23 hours agoMan dies in daylight shooting in Sydney’s north-west
-
General17 hours agoNewsCorp executive warns AI firms are asking Australia to ‘surrender our stories’
-
General12 hours agoRenters surprise winners from cheaper mortgage deposits
-
Noosa News24 hours agoUpper Lockyer man Robert Crawford faces court as wife Frances’s death ruled murder or accident